Medicines Consent Notices




NEW ZEALAND GAZETTE, No. 175

23 DECEMBER 2004


Product:

Active Ingredient:
Poly-O-(2-hydroxyethyl)-starch 6%w/v

Dosage Form:
Solution for injection

New Zealand Sponsor:
Biomed Limited

Manufacturer:
Biomed Limited, Pt Chevalier, Auckland


Product:

Hemohes


Product:

Active Ingredient:
Levetiracetam 1,000mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Muir Hutchison Limited

Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium


Product:

Keppra


Product:

Active Ingredient:
Levetiracetam 250mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Muir Hutchison Limited

Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium


Product:

Keppra


Product:

Active Ingredient:
Levetiracetam 500mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Muir Hutchison Limited

Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium


Product:

Keppra


Product:

Active Ingredient:
Levetiracetam 750mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Muir Hutchison Limited

Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium


Product:

Relestat

Active Ingredient:
Epinastine hydrochloride 0.5mg/mL

Dosage Form:
Eye drops, solution

New Zealand Sponsor:
Allergan New Zealand Limited

Manufacturer:
Allergan Pharmaceuticals Ireland, Westport, County Mayo, Ireland


Product:

Reminyl Prolonged Release Capsules (Combination Starter Pack)

Active Ingredient:
Galantamine hydrobromide 10.25mg equivalent to 8mg galantamine base

Dosage Form:
Capsule

Active Ingredient:
Galantamine hydrobromide 20.51mg equivalent to 16 mg galantamine base

Dosage Form:
Capsule

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy


Product:

Reminyl Prolonged Release Capsules

Active Ingredient:
Galantamine hydrobromide 20.51mg equivalent to 16mg galantamine base

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy


Product:

Reminyl Prolonged Release Capsules

Active Ingredient:
Galantamine hydrobromide 30.76mg equivalent to galantamine base 24mg

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy


Product:

Reminyl Prolonged Release Capsules

Active Ingredient:
Galantamine hydrobromide 10.25mg equivalent to galantamine base 8mg

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy


Product:

Yasmin

Active Ingredients:
Drospirenone 3mg
Ethinyloestradiol 30µg

Dosage Forms:
21 active film coated tablets
7 inactive film coated tablets

New Zealand Sponsor:
Schering (NZ) Limited

Manufacturer:
Schering GmbH und Co Produktions KG, Weimar, Germany



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 175


Gazette.govt.nz PDF NZ Gazette 2004, No 175





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines, New Medicines, Consent, Hemohes, Keppra, Levetiracetam, Relestat, Reminyl, Yasmin